BIO-TECHNE Corp (TECH)
Biological Products, (No Diagnostic Substances)
Latest Price
$72.27
TTM P/E
104.74
Normalized P/E
32.08
Div Yield
0.44%
Book Value
13.38
P/B Ratio
5.40
Valuation metrics
adjust assumptions →EPS: $1.16
Book value / share: $13.51
Formula: √(22.5 × EPS × BVPS)
Graham Number
$18.78
74% downside
Norm. op. income: $237M (median of 7yr)
Tax rate: 16%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$13.23
82% downside
Base FCF: $257M (median of recent 5yr)
Growth: 6%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$29.79
59% downside
EPS: $1.16
Target P/E: 32×
Formula: EPS × P/E
P/E Fair Value
$37.12
49% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.03M | $990.0M | 8.99% | +1.76M | 2026-06-30 |
| FMR LLC | 12.79M | $903.0M | 8.20% | +4.89M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.22M | $721.0M | 6.55% | +38.8K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 7.34M | $518.0M | 4.70% | +5.40M | 2026-06-30 |
| HBK INVESTMENTS L P | 6.83M | $482.0M | 4.37% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.51M | $459.0M | 4.17% | +26.0K | 2026-06-30 |
| MORGAN STANLEY | 6.37M | $450.0M | 4.08% | -2.16M | 2026-06-30 |
| STATE STREET CORP | 5.98M | $422.0M | 3.83% | +112.0K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.35M | $377.0M | 3.43% | +239.0K | 2026-06-30 |
| Invesco Ltd. | 4.99M | $352.0M | 3.19% | +397.7K | 2026-06-30 |